Concepedia

Hiroaki Ito

HI

Statistics

Publications

43

Citations

4K

H-Index

27

Active since

1994

Affiliations

Toho University(Current)

Hyogo Medical University

Keio University

Toho University Medical Center Sakura Hospital

The University of Tokyo

Hiroaki Ito is an author at Toho University specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and inflammation.

ORCID

Publications per year

1994–2024

43

Publications

43

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 925 citations

, , +11

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease☆

Hiroaki Ito, Masakazu Takazoe, Yoshihiro Fukuda et al. · Gastroenterology · 2004 · 639 citations · Full text

, , +13

IL-6 Is Required for the Development of Th1 Cell-Mediated Murine Colitis

Mitsunari Yamamoto, Kazuyuki Yoshizaki, Tadamitsu Kishimoto et al. · The Journal of Immunology · 2000 · 412 citations · Full text

, , +17

The IL-6R α chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo

Aysefa Doganci, Tatjana Eigenbrod, Norbert Krug et al. · Journal of Clinical Investigation · 2005 · 334 citations · Full text

, , +17

TREM‐2, triggering receptor expressed on myeloid cell‐2, negatively regulates TLR responses in dendritic cells

Hiroaki Ito, Jessica A. Hamerman · European Journal of Immunology · 2011 · 173 citations · Full text

, , +16

1–5 of 43